.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
McKesson
Covington
Express Scripts
Chinese Patent Office
Argus Health
US Department of Justice
Fuji
Medtronic
Deloitte

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200562

« Back to Dashboard
NDA 200562 describes CELECOXIB, which is a drug marketed by Alembic Pharms Ltd, Aurobindo Pharma Ltd, Lupin Ltd, Cipla Ltd, Mylan Pharms Inc, Jubilant Generics, Watson Labs Inc, Torrent Pharms Ltd, Macleods Pharms Ltd, Apotex Inc, and Teva, and is included in eleven NDAs. It is available from thirty-seven suppliers. Additional details are available on the CELECOXIB profile page.

The generic ingredient in CELECOXIB is celecoxib. There are twenty-five drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the celecoxib profile page.

Summary for NDA: 200562

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 200562

Suppliers and Packaging for NDA: 200562

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CELECOXIB
celecoxib
CAPSULE;ORAL 200562 ANDA Actavis Pharma, Inc. 0591-3982 0591-3982-05 500 CAPSULE in 1 BOTTLE (0591-3982-05)
CELECOXIB
celecoxib
CAPSULE;ORAL 200562 ANDA Actavis Pharma, Inc. 0591-3982 0591-3982-25 250 CAPSULE in 1 BOTTLE (0591-3982-25)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength50MG
Approval Date:Feb 11, 2015TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:Feb 11, 2015TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength200MG
Approval Date:Feb 11, 2015TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Cantor Fitzgerald
Citi
Harvard Business School
Fish and Richardson
US Army
Julphar
Cipla
Mallinckrodt
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot